Helisch, A; Thews, O; Buchholz, HG et al.
PET-Bildgebung von Kleintiertumoren: Dediziertes Kleintier-PET versus klinischer ScannerNuklearmedizin. Bd. 46. 2007 S. A28
Helisch, A; Fottner, C; Reber, H et al.
Pre-therapeutic dosimetry of metastatic neuroendocrine tumors: Implicatons for peptide receptor radiotherapyeingereicht. 2007 S. 1-
Vernaleken, I; Buchholz, HG; Kumakura, Y et al.
Prefrontal cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.Hum Brain Mapp. Bd. 28. 2007 S. 931-939
Landvogt, C
SPECT und PET in der Diagnostik von EpilepsienDer Nuklearmediziner. Bd. 3. 2007 S. 212-216
Fehr, C; Hohmann, N; Grunder, G et al.
Tiagabine does not attenuate alcohol-induced activation of the human reward system.Psychopharmacology. Bd. 191. H. 4. 2007 S. 975-83
Klega, A; Buchholz, HG; Müller, C et al.
Untersuchung zentraler opioiderger Korrelate von Persönlichkeitsmerkmalen gesunder ProbandenNuklearmedizin. Bd. 46. 2007 S. A56
Schreckenberger, M
"Ecstasy"-induced neurotoxicity: the contribution of functional brain imagingEur J Nucl Med Mol Imaging. Bd. 33. H. 2. 2006 S. 185-7
Helisch, A; Fottner, C; Schreckenberger, M et al.
1. Überlegenheit der F-18-DOPA-PET vs. Iod-123-MIBG-Szintigraphie zur präoperativen Lokalisation von extraadrenalen und multifokalen PhäochromozytomenParagangliomen. 44. Jahrestagung Nuklearmedizin Berlin,. 2006 S. V190
Bense, S; Best, C; Buchholz, HG et al.
18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.Neuroreport. Bd. 17. H. 6. 2006 S. 599-603
Schirrmacher, R; Bradtmoller, G; Schirrmacher, E et al.
18F-labeling of peptides by means of an organosilicon-based fluoride acceptorAngew Chem Int Ed Engl. Bd. 45. H. 36. 2006 S. 6047-50
Fottner, C; Rossmann, H; Schamberger, B et al.
A novel succinate dehydrogenase subunit D (SDHD) gene mutation, F136frameshift, causes familial malignant extraadrenal paragangliomas. 50th Annual Meeting of the German Society of EndocrinologyExp Clin Endocr Diab. Bd. 114. 2006 S. P05-060
Nguyen-Huu, BK; Urban, PP; Schreckenberger, M et al.
Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer.Mov Disord. Bd. 21. H. 8. 2006 S. 1285-7
Kunkel, Martin; Helisch, Andreas; Reichert, Torsten E. et al.
Clinical and prognostic value of [18F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapyOral oncology. OO. Bd. 42. H. 3. Kidlington: Elsevier Science 2006 S. 297 - 305
Werhahn, KJ; Landvogt, C; Klimpe, S et al.
Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET studyEpilepsia. Bd. 47. H. 8. 2006 S. 1392-6
Vander Borght, T; Asenbaum, S; Bartenstein, P et al.
EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues.Eur J Nucl Med Mol Imaging. Bd. 33. H. 11. 2006 S. 1374-80
Teipel, SJ; Drzezga, A; Bartenstein, P et al.
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.Psychopharmacology. Bd. 187. H. 1. 2006 S. 86-94
Buchmann, I; Hansen, T; Brochhausen, C et al.
FDG-PET in the initial staging of squamous cell oesophageal carcinoma.Nuklearmedizin. Bd. 45. H. 6. 2006 S. 235-41
Baumgartner, U; Buchholz, HG; Bellosevich, A et al.
High opiate receptor binding potential in the human lateral pain system.Neuroimage. Bd. 30. H. 3. 2006 S. 692-9
Vernaleken, I; Kumakura, Y; Cumming, P et al.
Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challengeNeuroimage. Bd. 30. H. 4. 2006 S. 1332-1339
Siessmeier, T; Kienast, T; Wrase, J et al.
Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.Eur J Neurosci. Bd. 24. H. 1. 2006 S. 305-13
Schreckenberger, MF; Egle, UT; Drecker, S et al.
Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidismJ Clin Endocrinol Metab. Bd. 91. 2006 S. 4786-91
Teipel, SJ; Willoch, F; Ishii, K et al.
Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.Neurobiol Aging. Bd. 27. H. 5. 2006 S. 681-90
Fottner, C; Helisch, A; Schreckenberger, M et al.
Superiority of 6-[18F]-Fluorodopamin Positron Emission Tomography (DOPA-PET) versus [123J]-Metaiodobenzylguanidine (MIBG) Scintigraphy in the localization of extraadrenal or multifocal pheochromocytomas and paragangliomoas. 50th Annual Meeting of the German Society of EndocrinologyExp Clin Endocr Diab. Bd. 114. 2006 S. P01-002
Schirrmacher, E; Beck, C; Brueckner, B et al.
Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases.Bioconjug Chem. Bd. 17. H. 2. 2006 S. 261-6
Gründer, G; Landvogt, C; Vernaleken, I et al.
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.Neuropsychopharmacology. Bd. 31. H. 5. 2006 S. 1027-35